Solventum Corp. logo

SOLVSolventum Corp.

NYSE · Healthcare · Medical Instruments & Supplies

$90.95

-$0.11 (-0.12%)

Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE. It is led by Bryan C. Hanson, based in 1750 Yankee Doodle Road, Eagan, MN, United States, 55121, with about 20,584 employees. Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Latest reported SOLV revenue for 2025-09-30 was $2.10B. Net income was $1.27B. Revenue was down 3.0% from 2025-06-30 to 2025-09-30. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.

Use this SOLV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SOLV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SOLV SEC filings page. Lician reads the product cache first so this HTML stays unique to Solventum Corp. even when a live quote feed is slow.

About Solventum Corp.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

SOLV Key Statistics

Market Cap

$12.91B

Volume

1.02M

Previous Close

$91.25

Day Range

$90.35$92.05

P/E Ratio

9.13

P/B Ratio

2.60

EPS

$2.76

Revenue

$8.25B

Net Income

$479.00M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+0.7%

Profit Margin

5.8%

Employees

20,584

SOLV Financials

Annual income statement in USD. Latest reported periods first.

SOLV annual income statement across FY2024, FY2023, FY2022
LineFY2024FY2023FY2022
Revenue$8.25B$8.20B$8.13B
Cost of Revenue$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00
Net Income$479.00M$1.35B$1.34B
EPS (Diluted)$2.76$7.79$7.78

Total Assets

$14.46B

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$762.00M

Operating Cash Flow

$1.19B

Free Cash Flow

$0.00

Solventum Corp. Company Information

CEO & Director
Bryan C. Hanson
Headquarters
1750 Yankee Doodle Road, Eagan, MN, United States, 55121
Phone
(651) 733-1110
IPO / Founded
2024-03-26
Industry
Medical Instruments & Supplies
Data Updated:

Upcoming Events for SOLV